X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 11/Sep 06:08

A promising new therapeutic target for MASLD identified

Using a novel stem cell platform, a team of the Medical University of South Carolina researchers has identified a pathway that could be targeted by drugs to reduce fat accumulation in patients with a common form of fatty liver disease known as metabolic dysfunction-associated steatotic liver disease, or MASLD.

Articles similaires

Discovery of stem-like CD4 T cells offers new hope for cancer immunotherapy

news.medical.net - 26/Oct 04:09

Researchers at Winship Cancer Institute of Emory University have identified a novel type of immune cell, called the stem-like CD4 T cell, that plays a...

Research reveals why some cancers are resistant to therapeutic drugs

oncologynews.com.au - 30/Oct 16:31

Polyploidy is a state where a cell contains more copies of the genetic material than the usual “diploid” cell, which contains two copies....

Clinical study confirms tissue stiffening in breast cancer can drive metastasis

oncologynews.com.au - 01/Nov 16:53

A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can...

Investigating the relationship between COPD and liver disease in alpha-1 antitrypsin deficiency

news.medical.net - 27/Oct 03:28

Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder characterized by the misfolding and accumulation of the mutant variant of alpha-1...

Fat-Derived Cellular Therapy: A New Hope for Diabetes Treatment

medindia.net - 28/Oct 21:13

Fat-Derived cellular therapy offers a promising new approach for diabetes, using cells from body fat to improve insulin function and potentially...

Researchers find ‘natural killer’ cells that live in the lung are ready for a sugar rush

oncologynews.com.au - 21/Oct 14:50

Trinity College Dublin researchers, Ireland, based at St James’s Hospital have provided important insights into the behaviour and metabolic function...

Biomarker may predict immunotherapy response in liver cancer

oncologynews.com.au - 30/Oct 14:32

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy,...

New drug, WNTinib, delays tumor growth and improves survival in mouse models of children’s liver cancer

oncologynews.com.au - 30/Oct 16:16

A new drug called WNTinib can delay the growth of tumours and improve survival in hepatoblastoma, a type of liver cancer that occurs in young...

Sorry! Image not available at this time

Ateneo study: There’s error in link of saturated fat to heart disease

businessmirror.com.ph - 26/Oct 16:05

Flaws were revealed in the 1950s studies on warnings against saturated fat on heart health, Ateneo de Manila University (ADMU) researchers said.

Sorry! Image not available at this time

Nurix Therapeutics presents positive results from phase 1a/1b trial of BTK degrader NX─5948 in patients with r/r Waldenstrom's macroglobulinemia at IWWM─12

pharmabiz.com - 23/Oct 02:51

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with...

Les derniers communiqués

  • Aucun élément